Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
9.00
+0.16 (1.81%)
At close: Dec 5, 2025, 4:00 PM EST
8.90
-0.10 (-1.11%)
After-hours: Dec 5, 2025, 4:00 PM EST
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$296,059
Profits / Employee
-$168,112
Market Cap
763.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VALN News
- 15 hours ago - VALNEVA Declaration of shares and voting rights: November 30, 2025 - GlobeNewsWire
- 9 days ago - Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings - Benzinga
- 9 days ago - Valneva to Further Consolidate its Operations in France - GlobeNewsWire
- 9 days ago - Valneva Shares Rise on Positive Data from Lyme Disease Vaccine Study - WSJ
- 10 days ago - Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate - GlobeNewsWire
- 15 days ago - Valneva SE (VALN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 weeks ago - Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate - GlobeNewsWire